BOSTON, Mass. and VANCOUVER, British Columbia, October 15, 2024 – Alpha-9 Oncology (“Alpha-9” or the “Company”), a clinical stage company developing radiopharmaceuticals for the treatment of cancer patients worldwide, announced the appointment of industry veterans Jean-Jacques Bienaimé and Steven Stein, MD to its board of directors. Mr.